Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    11%
    Check dated 2025-10-06T05:53:43.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.3%
    Check dated 2025-09-29T03:12:58.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; 'Back to Top' link removed. This is a minor maintenance update with no substantive content changes.
    Difference
    0.6%
    Check dated 2025-09-14T19:50:22.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.6%
    Check dated 2025-09-07T16:51:43.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with several updates to study statuses and recruitment timelines. Notably, the date for a study has been changed to August 28, 2025.
    Difference
    33%
    Check dated 2025-08-31T12:06:10.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T04:36:05.000Z thumbnail image

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.